Environmental source of Candida dubliniensis

Emerging Infectious Diseases

Volumn 13, Issue 5, 2007, Pages 747-750

  Nunn, Miles A ^a   Schäfer, Stefanie M ^a   Petrou, Michael A ^b   Brown, Jillian R M ^a  

^a NATURAL ENVIRONMENT RESEARCH COUNCIL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; RIBOSOME RNA; VORICONAZOLE;

ARTICLE; CANDIDA DUBLINIENSIS; DRUG SENSITIVITY; ENVIRONMENTAL EXPOSURE; FUNGAL STRAIN; FUNGUS ISOLATION; GENOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE;

EID: 34247880327     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1305.061179     Document Type: Article

References (15)

1. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol. 2004;42:4419-31.
2. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DA, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology. 1995;141:1507-21.
3. Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol. 1998;36:329-34.
4. Sullivan D, Haynes K, Bille J, Boerlin P, Rodero L, Lloyd S, et al. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol. 1997;35:960-4.
5. Sullivan DJ, Moran GP, Coleman DC. Candida dubliniensis: ten years on. FEMS Microbiol Lett. 2005;253:9-17.
6. Gee SF, Joly S, Soll DR, Meis JFGM, Verweij PE, Polacheck I, et al. Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo. J Clin Microbiol. 2002;40:556-74.
7. Blignaut E, Pujol C, Joly S, Soll DR. Racial distribution of Candida dubliniensis among South Africans. J Clin Microbiol. 2003;41:1838-42.
8. Buck JD. Isolation of Candida albicans and halophilic Vibrio spp. from aquatic birds in Connecticut and Florida. Appl Environ Microbiol. 1990;56:826-8.
9. Cafarchia C, Camarda A, Romito D, Campolo M, Quaglia NC, Tullio D, et al. Occurrence of yeast in cloacae of migratory birds. Mycopathologia. 2006;161:229-34.
10. Warren NG, Hazen KC. Candida, Cryptococcus and other yeasts of medical importance. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Volken RH, editors. Manual of clinical microbiology, 7th ed. Washington: ASM Press; 1999. p. 1184-99.
11. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeast, approved standard M27-A. Wayne (PA): The Committee, 1997.
12. White TJ, Bruns TD, Lee SB, Taylor JW. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sininsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego (CA): Academic Press Inc.; 1990. p. 315-22.
13. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser. 1999;41:95-8.
14. Gales AC, Pfaller MA, Houston AK, Joly S, Sullivan DJ, Coleman DC, et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-D-glucosidase as determined by API 20C AUX and Vitek YBC systems. J Clin Microbiol. 1999;37:3804-8.
15. Buck JD. A note on the experimental uptake and clearance of Candida albicans in a young captive gull (Larus sp.). Mycopathologia. 1986;94:59-61.